This study aimed to determine the prevalence of adult attention-deficit/hyperactivity disorder (ADHD) symptoms among individuals with opioid use disorder (OUD) and to examine whether impulsivity and aggression mediate the relationship between ADHD symptoms and addiction severity. A total of 100 individuals diagnosed with OUD and 50 healthy controls completed validated self-report measures assessing ADHD symptoms, impulsivity, aggression, and addiction severity. Compared with healthy controls, individuals with OUD exhibited significantly higher levels of ADHD symptoms, impulsivity, and aggression. Mediation analyses demonstrated that impulsivity partially mediated the association between ADHD symptoms and addiction severity, whereas aggression did not show a significant mediating effect. These findings suggest that the clinical impact of ADHD in OUD may be driven less by diagnostic status alone and more by specific impulsivity-related mechanisms. Identifying and targeting impulsivity may therefore represent an important strategy for improving clinical outcomes in individuals with OUD and comorbid ADHD symptoms.
AdlerL. A.FaraoneS. V.SpencerT. J.BerglundP.AlperinS.KesslerR. C. (2017). The structure of adult ADHD. International Journal of Methods in Psychiatric Research, 26(1), Article e1555. https://doi.org/10.1002/mpr.1555
2.
AinslieG. (2001). Breakdown of will. Cambridge University Press.
3.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders. American psychiatric association.
4.
ArıkanZ.CoşarB.IşıkA. (1996). Yarı kentsel bir bölgede alkolizm prevelansı [Prevalence of alcoholism in a semi-urban area]. Kriz Dergisi, 4(2), 93–100.
5.
BarkleyR. A.FischerM.SmallishL.FletcherK. (2002). The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. Journal of Abnormal Psychology, 111(2), 279–289. https://doi.org/10.1037/0021-843X.111.2.279
6.
BennettT.HollowayK.FarringtonD. (2008). The statistical association between drug misuse and crime: A meta-analysis. Aggression and Violent Behavior, 13(2), 107–118. https://doi.org/10.1016/j.avb.2008.02.001
7.
BeslotA.Grall-BronnecM.BalemM.SchreckB.LaforgueE. J.Victorri-VigneauC.Guillou-LandreatM.LeboucherJ.Challet-BoujuG.CabelguenC.OPAL-Group (2024). ADHD: Prevalence and effect on opioid use disorder treatment outcome in a French sample of patients receiving medication for opioid use disorder-the influence of impulsivity as a mediating factor. Harm Reduction Journal, 21(1), 165. https://doi.org/10.1186/s12954-024-01079-7
8.
BickelW. K.MarschL. A. (2001). Toward a behavioral economic understanding of drug dependence: Delay discounting processes. Addiction, 96(1), 73–86. https://doi.org/10.1046/j.1360-0443.2001.961736.x
9.
BickelW. K.MoodyL.QuisenberryA. J.RameyC. T.ShefferC. E. (2014). A Competing Neurobehavioral Decision Systems model of SES-related health and behavioral disparities. Preventive Medicine, 68(1), 37–43. https://doi.org/10.1016/j.ypmed.2014.06.023
10.
BiedermanJ.PettyC. R.O’ConnorK. B.HyderL. L.FaraoneS. V. (2012). Predictors of persistence in girls with attention deficit hyperactivity disorder: Results from an 11-year controlled follow-up study. Acta Psychiatrica Scandinavica, 125(2), 147–156. https://doi.org/10.1111/j.1600-0447.2011.01797.x
11.
BrowningL.CannoyC. N.MosesT. E. H.LundahlL. H.LedgerwoodD. M.GreenwaldM. K. (2024). Attention-deficit/hyperactivity disorder combined subtype exacerbates opioid use disorder consequences: Mediation by impulsive phenotypes. Drug and Alcohol Dependence, 259(1), Article 111292. https://doi.org/10.1016/j.drugalcdep.2024.111292
CananF.KulogluM.GuvenM.GeciciO. (2015). Reliability and validity of the Turkish version of the Clinical Opiate Withdrawal Scale (COWS). Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology, 25(3), 267–271. https://doi.org/10.5455/bcp.20150118042407
Demirtaş MadranH. A. (2013). Buss- Perry Saldırganlık Ölçeği’nin Türkçe formunun geçerlik ve güvenilirlik çalışması [The reliability and validity of the Buss-Perry Aggression Questionnaire (BAQ)–Turkish Version]. Turk Psikiyatri Dergisi (Turkish Journal of Psychiatry), 24(2), 124–129.
16.
FaraoneS. V.BiedermanJ.MickE. (2006). The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies. Psychological Medicine, 36(2), 159–165. https://doi.org/10.1017/S003329170500471X
17.
GareyL.OlofssonH.GarzaT.RogersA. H.KauffmanB. Y.ZvolenskyM. J. (2020). Directional effects of anxiety and depressive disorders with substance use: A review of recent prospective research. Current Addiction Reports, 7(3), 344–355. https://doi.org/10.1007/s40429-020-00321-z
18.
GiupponiG.InnamoratiM.RoganteE.SarubbiS.ErbutoD.ManiscalcoI.SannaL.ConcaA.LesterD.PompiliM. (2020). The characteristics of mood polarity, temperament, and suicide risk in adult ADHD. International Journal of Environmental Research and Public Health, 17(8), 2871. https://doi.org/10.3390/ijerph17082871
19.
GoodmanD. W.ThaseM. E. (2009). Recognizing ADHD in adults with comorbid mood disorders: Implications for identification and management. Postgraduate Medicine, 121(5), 20–30. https://doi.org/10.3810/pgm.2009.09.2049
20.
GratzK. L.RoemerL. (2004). Multidimensional assessment of emotion regulation and dysregulation: Development, factor structure, and initial validation of the difficulties in emotion regulation scale. Journal of Psychopathology and Behavioral Assessment, 26(1), 41–54. https://doi.org/10.1023/B:JOBA.0000007455.08539.94
21.
GüleçH.TamamL.GüleçM. Y.TurhanM.KarakuşG.ZenginM.StanfordM. S. (2008). Psychometric properties of the Turkish version of the Barratt Impulsiveness Scale-11. Klinik Psikofarmakoloji Bülteni, 18(4), 251–258.
22.
GünayŞ.SavranC.AksoyU. M.ManerF.TurgayA.Yargıçİ. (2006). Erişkin Dikkat Eksikliği Hiperaktivite ölçeğinin (Adult ADD/ADHD DSM IV based diagnostic screening and rating scale) dilsel eşdeğerlilik, geçerlik güvenirlik ve norm çalışması [Linguistic equivalence, validity, reliability and norm study of the Adult ADD/ADHD DSM IV based diagnostic screening and rating scale]. Türkiye’de Psikiyatri, 8(2), 98–107.
23.
KatzmanM. A.BilkeyT. S.ChokkaP. R.FalluA.KlassenL. J. (2017). Adult ADHD and comorbid disorders: Clinical implications of a dimensional approach. BMC Psychiatry, 17(1), 302. https://doi.org/10.1186/s12888-017-1463-3
24.
KooijJ. J. S.BijlengaD.SalernoL.JaeschkeR.BitterI.BalázsJ.ThomeJ.DomG.KasperS.Nunes FilipeC.StesS.MohrP.LeppämäkiS.CasasM.BobesJ.MccarthyJ. M.RicharteV.Kjems PhilipsenA.PehlivanidisA.AshersonP. (2019). Updated European Consensus Statement on diagnosis and treatment of adult ADHD. European Psychiatry: The Journal of the Association of European Psychiatrists, 56(1), 14–34. https://doi.org/10.1016/j.eurpsy.2018.11.001
25.
KrauszM.VertheinU.DegkwitzP. (1999). Psychiatric comorbidity in opiate addicts. European Addiction Research, 5(2), 55–62. https://doi.org/10.1159/000018966
26.
MarxI.HackerT.YuX.CorteseS.Sonuga-BarkeE. (2021). ADHD and the choice of small immediate over larger delayed rewards: A comparative meta-analysis of performance on simple choice-delay and temporal discounting paradigms. Journal of Attention Disorders, 25(2), 171–187. https://doi.org/10.1177/1087054718772138
27.
McLellanA. T.LewisD. C.O’BrienC. P.KleberH. D. (2000). Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA, 284(13), 1689–1695. https://doi.org/10.1001/jama.284.13.1689
28.
MooreF. R.DoughtyH.NeumannT.McClellandH.AllottC.O'ConnorR. C. (2022). Impulsivity, aggression, and suicidality relationship in adults: A systematic review and meta-analysis. eClinicalMedicine, 45(1), Article 101307. https://doi.org/10.1016/j.eclinm.2022.101307
29.
OgelK.EvrenC.KaradağF.AksoyC. M.EremM.GürolD. T. (2012). Bağımlılık profil indeksi’nin (API) geliştirilmesi, geçerlik ve güvenilirliği [Development, validity and reliability of the Addiction Profile Index (API)]. Türk Psikiyatri Dergisi, 23(4), 264–273.
30.
ParkT. W.BaulT. D.MorganJ. R.WilensT. E.YuleA. M. (2024). Trends in attention-deficit hyperactivity disorder diagnosis and pharmacotherapy among adults with opioid use disorder. Psychiatric Services, 75(3), 214–220. https://doi.org/10.1176/appi.ps.20220400
QuinnP. O.MadhooM. (2014). A review of attention-deficit/hyperactivity disorder in women and girls: Uncovering this hidden diagnosis. The Primary Care Companion for CNS Disorders, 16(3), PCC.13r01596. https://doi.org/10.4088/PCC.13r01596
33.
RajiH.DineshS.SharmaS. (2025). Inside the impulsive brain: A narrative review on the role of neurobiological, hormonal and genetic factors influencing impulsivity in psychiatric disorders. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 61(1), 4. https://doi.org/10.1186/s41983-024-00930-9
RucklidgeJ. J. (2010). Gender differences in attention-deficit/hyperactivity disorder. Psychiatric Clinics of North America, 33(2), 357–373. https://doi.org/10.1016/j.psc.2010.01.006
36.
ShawP.StringarisA.NiggJ.LeibenluftE. (2014). Emotion dysregulation in attention deficit hyperactivity disorder. American Journal of Psychiatry, 171(3), 276–293. https://doi.org/10.1176/appi.ajp.2013.13070966
37.
StoltmanJ. J. K.WoodcockE. A.ListerJ. J.LundahlL. H.GreenwaldM. K. (2015). Heroin delay discounting: Modulation by pharmacological state, drug-use impulsivity, and intelligence. Experimental and Clinical Psychopharmacology, 23(6), 455–463. https://doi.org/10.1037/pha0000045
Substance Abuse and Mental Health Services Administration [SAMHSA]. (2020). Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health.
40.
TurgayA. (1995). DSM-IV-based adult hyperactivity rating scale. Integrative Therapy Institute.
van Emmerik-van OortmerssenK.van de GlindG.van den BrinkW.SmitF.CrunelleC. L.SwetsM.SchoeversR. A. (2012). Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysis. Drug and Alcohol Dependence, 122(1-2), 11–19. https://doi.org/10.1016/j.drugalcdep.2011.12.007
43.
WattersJ. K.ReinarmanC.FaganJ. (1985). Causality, context, and contingency: Relationships between drug abuse and delinquency. Contemporary Drug Problems, 12(3), 351–373.
WhitesideS. P.LynamD. R. (2001). The five factor model and impulsivity: Using a structural model of personality to understand impulsivity. Personality and Individual Differences, 30(4), 669–689. https://doi.org/10.1016/S0191-8869(00)00064-X
46.
WillcuttE. G. (2012). The prevalence of DSM-IV attention-deficit/hyperactivity disorder: A meta-analytic review. Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics, 9(3), 490–499. https://doi.org/10.1007/s13311-012-0135-8
47.
WitkiewitzK.LittenR. Z.LeggioL. (2019). Advances in the science and treatment of alcohol use disorder. Science Advances, 5(9), eaax4043. https://doi.org/10.1126/sciadv.aax4043
48.
World Health Organization. (2019). International statistical classification of diseases and related health problems (11th ed.). World Health Organization.
49.
YoungS.AdamoN.ÁsgeirsdóttirB. B.BranneyP.BeckettM.ColleyW.CubbinS.DeeleyQ.FarragE.GudjonssonG.HillP.HollingdaleJ.KilicO.LloydT.MasonP.PaliokostaE.PerecherlaS.SedgwickJ.SkirrowC.WoodhouseE. (2020). Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/hyperactivity disorder in girls and women. BMC Psychiatry, 20(1), 404. https://doi.org/10.1186/s12888-020-02707-9
